Specificity and effect on apoptosis of Tat antibodies from vaccinated and SHIV-infected rhesus macaques and HIV-infected individuals
- PMID: 12804847
- DOI: 10.1016/s0264-410x(03)00233-0
Specificity and effect on apoptosis of Tat antibodies from vaccinated and SHIV-infected rhesus macaques and HIV-infected individuals
Abstract
Recent contributions have demonstrated that actively secreted Tat protein plays an important functional role in human immunodeficiency virus-1 (HIV-1) infection and that Tat antibodies might interfere with disease progression by blocking the protein extracellularly. In this context we have studied the recognition of several Tat mutants as well as various synthetic Tat fragments by anti-Tat monoclonal antibodies and by IgG antibodies from a large collection of slow and fast-progressor infected individuals. We have also tested the sera from simian/human immunodeficiency virus (SHIV)-infected macaques with these Tat peptides. Important differences were found between long-term non-progressors and fast-progressors, and between human and monkey sera in terms of antibody specificity. Rabbits and macaques were immunised with several Tat peptides and we found that certain antibody subsets from immunised animals recognised the cognate protein Tat and had the capacity to inhibit Tat-induced apoptosis of T cells. Such antibodies might be important for controlling Tat-induced death in cells uninfected by HIV-1.
Similar articles
-
Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV33).Vaccine. 2000 Jun 15;18(25):2789-95. doi: 10.1016/s0264-410x(00)00085-2. Vaccine. 2000. PMID: 10812220
-
Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein.J Virol. 2002 Apr;76(8):3800-9. doi: 10.1128/jvi.76.8.3800-3809.2002. J Virol. 2002. PMID: 11907220 Free PMC article.
-
Evaluation in rhesus macaques of Tat and rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08.DNA Cell Biol. 2002 Sep;21(9):653-8. doi: 10.1089/104454902760330183. DNA Cell Biol. 2002. PMID: 12396607
-
Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.J Virol. 2005 Feb;79(3):1452-62. doi: 10.1128/JVI.79.3.1452-1462.2005. J Virol. 2005. PMID: 15650171 Free PMC article.
-
Antigenic variation of primate lentiviruses in humans and experimentally infected macaques.Immunol Rev. 1994 Aug;140:131-46. doi: 10.1111/j.1600-065x.1994.tb00868.x. Immunol Rev. 1994. PMID: 7821925 Review.
Cited by
-
Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine.Retrovirology. 2006 Jan 27;3:8. doi: 10.1186/1742-4690-3-8. Retrovirology. 2006. PMID: 16441880 Free PMC article.
-
Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein.J Virol. 2004 Dec;78(23):13190-6. doi: 10.1128/JVI.78.23.13190-13196.2004. J Virol. 2004. PMID: 15542671 Free PMC article.
-
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.J Virol. 2007 Apr;81(7):3414-27. doi: 10.1128/JVI.02453-06. Epub 2007 Jan 17. J Virol. 2007. PMID: 17229693 Free PMC article.
-
What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?Retrovirology. 2009 May 25;6:50. doi: 10.1186/1742-4690-6-50. Retrovirology. 2009. PMID: 19467159 Free PMC article. Review.
-
Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen.J Virol. 2004 Apr;78(7):3792-6. doi: 10.1128/jvi.78.7.3792-3796.2004. J Virol. 2004. PMID: 15016898 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical